Статті в журналах з теми "Exenatide (exendin-4)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-40 статей у журналах для дослідження на тему "Exenatide (exendin-4)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Wei, Rui, Shifeng Ma, Chen Wang, Jing Ke, Jin Yang, Weihong Li, Ye Liu, et al. "Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner." American Journal of Physiology-Endocrinology and Metabolism 310, no. 11 (June 1, 2016): E947—E957. http://dx.doi.org/10.1152/ajpendo.00400.2015.
Повний текст джерелаZhang, Aihong, Yin Lin, Shirly Nong, Wei Zhao, and Mei Dong. "Engineering a protease-based and site-specific PEGylation-based strategy for the controlled release of exenatide." RSC Advances 10, no. 42 (2020): 25013–21. http://dx.doi.org/10.1039/d0ra01010c.
Повний текст джерелаZhao, Qian, Chun-ling Xu, Hai-yan Xiong, Wen Huang, Mei Zhang, Yun Wang, Si-yu Wang, and Wen Wang. "Alleviation of Hyperglycemia Induced Vascular Endothelial Injury by Exenatide Might Be Related to the Reduction of Nitrooxidative Stress." BioMed Research International 2013 (2013): 1–11. http://dx.doi.org/10.1155/2013/843657.
Повний текст джерелаMcCord, Amie D. "Exenatide: A Novel Therapeutic Approach for Type 2 Diabetes Mellitus." Journal of Pharmacy Technology 21, no. 4 (July 2005): 191–96. http://dx.doi.org/10.1177/875512250502100402.
Повний текст джерелаDenker, P. S., and P. E. Dimarco. "Exenatide (Exendin-4)-Induced Pancreatitis: A case report." Diabetes Care 29, no. 2 (January 27, 2006): 471. http://dx.doi.org/10.2337/diacare.29.02.06.dc05-2043.
Повний текст джерелаKosowska, Agnieszka, Enrique Gallego-Colon, Wojciech Garczorz, Agnieszka Kłych-Ratuszny, Mohammad Reza F. Aghdam, Michał Woz´niak, Andrzej Witek, et al. "Exenatide modulates tumor–endothelial cell interactions in human ovarian cancer cells." Endocrine Connections 6, no. 8 (November 2017): 856–65. http://dx.doi.org/10.1530/ec-17-0294.
Повний текст джерелаHiles, Richard A., Roger E. Bawdon, and Ezio M. Petrella. "Ex vivo human placental transfer of the peptides pramlintide and exenatide (synthetic exendin-4)." Human & Experimental Toxicology 22, no. 12 (December 2003): 623–28. http://dx.doi.org/10.1191/0960327103ht402oa.
Повний текст джерелаKawasaki, Yukiko, Yoshiyuki Hamamoto, and Hiroyuki Koshiyama. "Species-Specific Actions of Incretin: From the Evolutionary Perspective." Japanese Clinical Medicine 1 (January 2010): JCM.S5915. http://dx.doi.org/10.4137/jcm.s5915.
Повний текст джерелаNachnani, J. S., D. G. Bulchandani, A. Nookala, B. Herndon, A. Molteni, P. Pandya, R. Taylor, T. Quinn, L. Weide, and L. M. Alba. "Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas." Diabetologia 53, no. 1 (September 13, 2009): 153–59. http://dx.doi.org/10.1007/s00125-009-1515-4.
Повний текст джерелаCalara, F. "Effect of injection site on relative bioavailability of exenatide (synthetic exendin-4)." Clinical Pharmacology & Therapeutics 75, no. 2 (February 2004): P58. http://dx.doi.org/10.1016/j.clpt.2003.11.221.
Повний текст джерелаChia, Chee W., and Josephine M. Egan. "Incretin-Based Therapies in Type 2 Diabetes Mellitus." Journal of Clinical Endocrinology & Metabolism 93, no. 10 (October 1, 2008): 3703–16. http://dx.doi.org/10.1210/jc.2007-2109.
Повний текст джерелаHadjiyanni, Irene, Laurie L. Baggio, Philippe Poussier, and Daniel J. Drucker. "Exendin-4 Modulates Diabetes Onset in Nonobese Diabetic Mice." Endocrinology 149, no. 3 (December 6, 2007): 1338–49. http://dx.doi.org/10.1210/en.2007-1137.
Повний текст джерелаVictor, Suresh, Eridan Rocha-Ferreira, Ahad Rahim, Henrik Hagberg, and David Edwards. "New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy." European Journal of Pediatrics 181, no. 3 (November 24, 2021): 875–87. http://dx.doi.org/10.1007/s00431-021-04320-8.
Повний текст джерелаHolst, Jens Juul. "Pharmacology of GLP-1-based therapies." British Journal of Diabetes & Vascular Disease 8, no. 2_suppl (November 2008): S10—S18. http://dx.doi.org/10.1177/1474651408100523.
Повний текст джерелаKolterman, Orville G., John B. Buse, Mark S. Fineman, Eling Gaines, Sonja Heintz, Thomas A. Bicsak, Kristin Taylor, et al. "Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes." Journal of Clinical Endocrinology & Metabolism 88, no. 7 (July 1, 2003): 3082–89. http://dx.doi.org/10.1210/jc.2002-021545.
Повний текст джерелаNielsen, Loretta L., Andrew A. Young, and David G. Parkes. "Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes." Regulatory Peptides 117, no. 2 (February 2004): 77–88. http://dx.doi.org/10.1016/j.regpep.2003.10.028.
Повний текст джерелаDegn, K. B., B. Brock, C. B. Juhl, C. B. Djurhuus, J. Grubert, D. Kim, J. Han, K. Taylor, M. Fineman, and O. Schmitz. "Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During Hypoglycemia." Diabetes 53, no. 9 (August 26, 2004): 2397–403. http://dx.doi.org/10.2337/diabetes.53.9.2397.
Повний текст джерелаCalara, Federico, Kristin Taylor, Jenny Han, Evelyn Zabala, Eh Moo Carr, Matthew Wintle, and Mark Fineman. "A randomized, open-label, crossover study examiningthe effect of injection site on bioavailability of exenatide (synthetic exendin-4)." Clinical Therapeutics 27, no. 2 (February 2005): 210–15. http://dx.doi.org/10.1016/j.clinthera.2005.02.008.
Повний текст джерелаFigat, Magdalena, Grzegorz Kardas, Piotr Kuna, and Michał G. Panek. "Beneficial Influence of Exendin-4 on Specific Organs and Mechanisms Favourable for the Elderly with Concomitant Obstructive Lung Diseases." Brain Sciences 12, no. 8 (August 17, 2022): 1090. http://dx.doi.org/10.3390/brainsci12081090.
Повний текст джерелаGallwitz, Baptist. "GLP-1 Receptor Agonists in Type 2 Diabetes and Beyond – New Insights 2015." US Endocrinology 11, no. 01 (2015): 47. http://dx.doi.org/10.17925/use.2015.11.1.47.
Повний текст джерелаGallwitz, Baptist. "GLP-1 Receptor Agonists in Type 2 Diabetes and Beyond – New Insights 2015." European Endocrinology 11, no. 1 (2015): 21. http://dx.doi.org/10.17925/ee.2015.11.01.21.
Повний текст джерелаBuse, J. B., R. R. Henry, J. Han, D. D. Kim, M. S. Fineman, and A. D. Baron. "Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes." Diabetes Care 27, no. 11 (October 25, 2004): 2628–35. http://dx.doi.org/10.2337/diacare.27.11.2628.
Повний текст джерелаDeFronzo, R. A., R. E. Ratner, J. Han, D. D. Kim, M. S. Fineman, and A. D. Baron. "Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes." Diabetes Care 28, no. 5 (April 26, 2005): 1092–100. http://dx.doi.org/10.2337/diacare.28.5.1092.
Повний текст джерелаMack, C. M., C. X. Moore, C. M. Jodka, S. Bhavsar, J. K. Wilson, J. A. Hoyt, J. L. Roan, et al. "Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures." International Journal of Obesity 30, no. 9 (March 14, 2006): 1332–40. http://dx.doi.org/10.1038/sj.ijo.0803284.
Повний текст джерелаWright, F. L., and R. J. Rodgers. "G.11 - BEHAVIOURAL PROFILE OF GLP-1 RECEPTOR AGONIST, EXENDIN-4 (EXENATIDE), IN NON-DEPRIVED MALE RATS PRESENTED WITH PALATABLE MASH." Behavioural Pharmacology 24 (October 2013): e59. http://dx.doi.org/10.1097/01.fbp.0000434879.77693.f7.
Повний текст джерелаFineman, Mark S., Larry Z. Shen, Kristin Taylor, Dennis D. Kim, and Alain D. Baron. "Effectiveness of progressive dose-escalation of exenatide(exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes." Diabetes/Metabolism Research and Reviews 20, no. 5 (August 27, 2004): 411–17. http://dx.doi.org/10.1002/dmrr.499.
Повний текст джерелаGedulin, Bronislava R., Svetlana E. Nikoulina, Pamela A. Smith, George Gedulin, Loretta L. Nielsen, Alain D. Baron, David G. Parkes та Andrew A. Young. "Exenatide (Exendin-4) Improves Insulin Sensitivity and β-Cell Mass in Insulin-Resistant Obesefa/faZucker Rats Independent of Glycemia and Body Weight". Endocrinology 146, № 4 (квітень 2005): 2069–76. http://dx.doi.org/10.1210/en.2004-1349.
Повний текст джерелаBlase, Erich, Kristin Taylor, Hong-ye Gao, Matthew Wintle, and Mark Fineman. "Pharmacokinetics of an Oral Drug (Acetaminophen) Administered at Various Times in Relation to Subcutaneous Injection of Exenatide (Exendin-4) in Healthy Subjects." Journal of Clinical Pharmacology 45, no. 5 (May 2005): 570–77. http://dx.doi.org/10.1177/0091270004274432.
Повний текст джерелаKendall, D. M., M. C. Riddle, J. Rosenstock, D. Zhuang, D. D. Kim, M. S. Fineman, and A. D. Baron. "Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea." Diabetes Care 28, no. 5 (April 26, 2005): 1083–91. http://dx.doi.org/10.2337/diacare.28.5.1083.
Повний текст джерелаFineman, M. S., T. A. Bicsak, L. Z. Shen, K. Taylor, E. Gaines, A. Varns, D. Kim, and A. D. Baron. "Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes." Diabetes Care 26, no. 8 (July 25, 2003): 2370–77. http://dx.doi.org/10.2337/diacare.26.8.2370.
Повний текст джерелаKennedy, L. "Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea." Yearbook of Endocrinology 2006 (January 2006): 1–4. http://dx.doi.org/10.1016/s0084-3741(08)70258-0.
Повний текст джерелаSathavarodom, Nattapol, Thanasate Roongjiraroj, and Verapon Pinphanichakarn. "ODP222 Liragluitde Increased IL-1RA Concentrations in Obese Type 2 Diabetes: A Small Randomized Controlled Trial." Journal of the Endocrine Society 6, Supplement_1 (November 1, 2022): A325. http://dx.doi.org/10.1210/jendso/bvac150.673.
Повний текст джерелаBailey, Clifford J. "origins of type 2 diabetes medications." British Journal of Diabetes 22, no. 2 (December 21, 2022): 112–20. http://dx.doi.org/10.15277/bjd.2022.388.
Повний текст джерелаMartins, Flavia L., Matthew A. Bailey, and Adriana C. C. Girardi. "Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Blood Pressure Control." Hypertension 76, no. 3 (September 2020): 839–48. http://dx.doi.org/10.1161/hypertensionaha.120.14868.
Повний текст джерелаPoon, Terri, Kristin Taylor, Loretta Nielsen, Sarah Boies, Dongliang Zhuang, Amanda Varns, Jay Zhou, et al. "Abstract #20: Effects of Exenatide (Synthetic Exendin-4) on Glucose Control and Safety in Patients with Type 2 Diabetes Treated with Metformin, a Sulfonylurea, or Both: An Ongoing, Open-Label Phase 3 Trial." Endocrine Practice 10 (March 2004): 7. http://dx.doi.org/10.1016/s1530-891x(20)46299-8.
Повний текст джерелаWajchenberg, Bernardo L. "β-Cell Failure in Diabetes and Preservation by Clinical Treatment". Endocrine Reviews 28, № 2 (12 березня 2007): 187–218. http://dx.doi.org/10.1210/10.1210/er.2006-0038.
Повний текст джерелаWinkler, Gábor. "Incretin enhancers, incretin mimetics – from therapeutic concept to clinical application." Orvosi Hetilap 148, no. 13 (April 1, 2007): 579–87. http://dx.doi.org/10.1556/oh.2007.28093.
Повний текст джерелаAkter, Shammi, Shajia Afrin, Jaeyoon Kim, Joohyun Kang, Md Abdur Razzak, Per-Olof Berggren, and Inhwan Hwang. "Production of active Exendin-4 in Nicotiana benthamiana and its application in treatment of type-2 diabetics." Frontiers in Plant Science 13 (December 22, 2022). http://dx.doi.org/10.3389/fpls.2022.1062658.
Повний текст джерелаROSSELOT, CAROLINA, YANSUI LI, DANIELA GUEVARA, KARA A. BELIARD, RANDY KANG, PENG WANG, KEYA THAKKAR, et al. "14-OR: Harmine and Exenatide Combination Increases Human ß-Cell Survival." Diabetes 71, Supplement_1 (June 1, 2022). http://dx.doi.org/10.2337/db22-14-or.
Повний текст джерелаSU, YANNA, BEISI LIN, YALAN CHEN, ZIYU LIU, LU GAN, and WEN XU. "1518-PUB: Role of PPARd in Regulating Autophagy Pathway in Improving Islet ß-Cell Function with GLP-1 Receptor Agonist." Diabetes 71, Supplement_1 (June 1, 2022). http://dx.doi.org/10.2337/db22-1518-pub.
Повний текст джерела